Genomics

Dataset Information

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial


ABSTRACT: The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

PROVIDER: PRJNA1088758 | ENA |

REPOSITORIES: ENA